[Federal Register: August 27, 2002 (Volume 67, Number 166)]
[Notices]
[Page 55017-55018]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27au02-57]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 02032]
Cooperative Agreement to the Medical Research Council of South
Africa (MRC) for Tuberculosis Control Activities; Notice of Award of
Funds
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
award of fiscal year (FY) 2002 funds for a sole source cooperative
agreement for the Medical Research Council of South Africa (MRC).
The purpose of this program is to help support and ensure
implementation of tuberculosis (TB) control activities that are
designed to develop, establish, and coordinate systems and procedures
to address the obstacles to achieving control of TB and multi-drug
tuberculosis (MDR-TB) in South Africa.
[[Page 55018]]
These collaborative activities can profoundly change the focus and
activities of the South African National TB Control Program and improve
TB treatment and control programs and related prevention efforts in
South Africa.
B. Eligible Applicants
Assistance will be provided only to the Medical Research Council
(MRC) of South Africa. No other applications will be solicited. MRC
will support and ensure implementation of tuberculosis (TB) control
activities that are designed to develop, establish, and coordinate
systems and procedures to address the obstacles to achieving control of
tuberculosis and multi-drug tuberculosis (MDR-TB) in South Africa.
MRC is the most appropriate and qualified agency to conduct the
activities under this cooperative agreement because:
1. The MRC is uniquely positioned, in terms of legal authority,
ability, track record, and credibility in South Africa to develop and
support TB control activities in both public and non-governmental
organization sites throughout the country.
2. The MRC has already established mechanisms to develop and
implement TB treatment services in South Africa, enabling it to
immediately become engaged in the activities listed in this
announcement.
3. The purpose of the announcement is to build upon the existing
framework of TB control activities that the MRC has developed or
initiated.
4. The MRC has been mandated by the South African government to
coordinate and implement TB treatment and control activities including
MDR-TB within the country.
5. MRC has a unique and unparalleled involvement with the Ministry
of Health's National Tuberculosis Control Program (NTP) and the South
African National Tuberculosis Association (SANTA) based on a history of
collaboration.
6. MRC coordinates the research and development activities for the
Global Alliance for TB Drug Development in the search for a better,
more effective and affordable cure for TB that is shorter, equally
effective against susceptible and drug-resistant TB, accessible to the
populations that need it most, and be on the market in less than 10
years.
C. Funds
Approximately $307,000 is being awarded in FY 2002. The award will
be made by July 1, 2002, for a 12-month budget period within a project
period of up to five years.
D. Where To Obtain Additional Information
If you have questions after reviewing the contents of all the
documents, business management technical assistance may be obtained
from:
Angelia D. Hill, Grants Management Specialist, Grants Management
Branch, Procurement and Grants Office, Centers for Disease Control and
Prevention, 2920 Brandywine Road, MS E-09, Atlanta, GA 30341-4146,
Telephone: (770) 488-2785, FAX: (770) 488-2688, E-mail: aph8@cdc.gov.
Michael Qualls, Deputy Associate Director, International
Activities, Division of Tuberculosis Elimination, National Center for
HIV, STD, and TB Prevention Centers for Disease Control and Prevention
(CDC), 1600 Clifton Road Mailstop E-10, Atlanta, GA 30333, Telephone
404-639-8488, Email address: muq1@cdc.gov.
Dated: August 20, 2002.
Sandra R. Manning, CGFM,
Director, Procurement and Grants Office, Centers for Disease Control &
Prevention.
[FR Doc. 02-21731 Filed 8-26-02; 8:45 am]
BILLING CODE 4163-18-P